Ingevity - Shrinking To Grow
Ingevity Corporation is implementing a shrink-to-grow strategy by divesting non-core assets to enhance focus and profitability. The company has recently sold some assets at modest prices, which followed significant impairment charges but did not significantly affect earnings. With a target of $4.70–$5.20 EPS and $370–$395 million adjusted EBITDA for 2026, there is cautious optimism for potential re-rating if further simplification or a spin-off occurs.
- ▪Ingevity is divesting non-core assets to improve focus and margins.
- ▪Recent asset sales have been modest in price and followed significant impairment charges.
- ▪The company is targeting $4.70–$5.20 EPS and $370–$395 million adjusted EBITDA for 2026.
Seeking Alpha files mainly under finance. We currently carry 6,390 of its stories.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Basic Materials","item":"https://seekingalpha.com/stock-ideas/basic-materials"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4906287-ingevity-stock-q1-shrinking-to-grow-maintain-hold"},"author":{"@type":"Person","name":"The Value Investor","url":"https://seekingalpha.com/author/the-value-investor"},"publisher":{"@context":"http://schema.org","@type":"Organization","address":{"@type":"PostalAddress","streetAddress":"244 5th Ave","addressLocality":"New…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
